The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals
Open accessPublished version of a preprint
Abstract
Fecal calprotectin is an established marker of gut inflammation in inflammatory bowel disease (IBD). Elevated levels of fecal calprotectin as well as gut microbial dysbiosis have also been observed in other clinical conditions. However, systemic and multi-omics alterations linked to elevated fecal calprotectin in older individuals remain unclear. This study comprehensively investigated the relationship between fecal calprotectin levels, gut microbiome composition, serum inflammation and targeted metabolomics markers, and relevant lifestyle and medical data in a large sample of older individuals (n = 735; mean age ± SD: 68.7 ± 6.3) from the TREND cohort study. Low (0–50 μg/g; n = 602), moderate (> 50–100 μg/g; n = 64) and high (> 100 μg/g; n = 62) fecal calprotectin groups were stratified. Several pro-inflammatory gut microbial genera were significantly increased and short-chain fatty acid producing genera were decreased in high vs. low calprotectin groups. In serum, IL-17C, CCL19 and the toxic metabolite indoxyl sulfate were increased in high vs. low fecal calprotectin groups. These changes were partially mediated by the gut microbiota. Moreover, the high fecal calprotectin group showed increased BMI and a higher disease prevalence of heart attack and obesity. Our findings contribute to the understanding of fecal calprotectin as a marker of gut dysbiosis and its broader systemic and clinical implications in older individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is an established, sensitive marker used to monitor IBD activity and, by extension, reflects microbiota-driven mucosal inflammation.119,121,122”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25788 · Cited by 95
Self-citationRetractedphyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,322
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K., & Schloss, P. D. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01043-13 · Cited by 7,112
PICRUSt2 for prediction of metagenome functions
Douglas, G. M., Maffei, V. J., Zaneveld, J. R., Yurgel, S. N., Brown, J. R., Taylor, C. M., Huttenhower, C., & Langille, M. G. I. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0548-6 · Cited by 6,709
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586 · cited 1×
“Gut inflammation, even at moderate yet chronic levels, may be involved in various disease processes affecting the central nervous system via the gut-brain axis 4 and inflammaging 5 .”
BackgroundThe Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication
Silva, Y. P., Bernardi, A., & Frozza, R. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00025 · Cited by 3,043
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137 · cited 1×
“Local and systemic pro-inflammatory effects have been partly linked to gut microbial dysbiosis not only in IBD 10 but also other inflammatory diseases 11 as well as numerous neurodegenerative 12,13 , metabolic 14 and cardiovascular diseases (CVD) 15 .”
BackgroundGut microbiome structure and metabolic activity in inflammatory bowel disease
Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995 · cited 1×
“Local and systemic pro-inflammatory effects have been partly linked to gut microbial dysbiosis not only in IBD 10 but also other inflammatory diseases 11 as well as numerous neurodegenerative 12,13 , metabolic 14 and cardiovascular diseases (CVD) 15 .”
Background
Cited by
Role of Gut Microbiota in Modulating Oxidative Stress Induced by Environmental Factors
Kurhaluk, N., Kamiński, P., & Tkaczenko, H. (2025) · Cellular Physiology and Biochemistry · doi:10.33594/000000799 · Cited by 38
Zheng, J., & Lin, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1629944 · Cited by 27
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
Deza, D. C., García‐López, S., Monterde, V. B., Cuadro, C. P., Caballero, C. Y., & Arbonés-Mainar, J. M. (2025) · Biomolecules · doi:10.3390/biom15081185 · Cited by 24
Šantić, R., Pavlović, N., Kumrić, M., Vilović, M., & Božić, J. (2025) · Biomedicines · doi:10.3390/biomedicines13081864 · Cited by 19
Metadata
- Authors
- Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., Auvinen, P., Maetzler, W., Berg, D., & Scheperjans, F.
- Affiliations
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital Schleswig-Holstein (DE)
- University of Helsinki (FI)
- Universitätsklinikum Tübingen (DE)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Heinzel, Sebastian
- ORCID
- Venue
- Scientific Reports
- Published
- 2024-06-12
- Volume
- 14
- Issue
- 1
- Pages
- 13513-13513
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC11169261
- OpenAlex
- W4399576367
- Cited by
- 36
- References
- 65
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 1
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Multimedialen Archiv und Publikationsserver der Christian-Albrechts-Universität zu Kiel (Christian-Albrechts-Universität zu Kiel) (submittedVersion, cc-by)
- DZNE Pub (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Germany Research Society (675915)
- Research Council of Finland (310835)
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal calprotectin, gut dysbiosis, gut microbiota, older adults, IL-17C, CCL19, indoxyl sulfate, short-chain fatty acids, metabolomics, obesity, myocardial infarction
- MeSH terms
- Gastrointestinal Microbiome, Aged, Feces, Female, Humans, Male, Middle Aged, Inflammatory Bowel Diseases, Cohort Studies, Biomarkers, Leukocyte L1 Antigen Complex, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. https://app.cochat.ai/papers/10.1038/s41598-024-63893-0
- The paper
- Heinzel, S., Jureczek, J., Kainulainen, V., Nieminen, A. I., Suenkel, U., von Thaler, A.-K., Kaleta, C., Eschweiler, G. W., Brockmann, K., Aho, V. T. E., Auvinen, P., Maetzler, W., Berg, D., & Scheperjans, F. (2024). Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Scientific Reports. https://doi.org/10.1038/s41598-024-63893-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.